Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129242) titled 'Efficacy and Safety of Imipenem Cilastatin Injection versus Standard-of-Care Regimen in Patients with Multidrug-Resistant Pseudomonas aeruginosa Infection: A Multicenter Prospective Cohort Study' on Aug. 1.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Tongde Hospital of Zhejiang Province
Condition:
Multidrug-Resistant Pseudomonas Aeruginosa (MDR-PA) infection.
Intervention:
standard-of-care anti-infective regimens group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-08-10
Target Sample Size: standard-of-care anti-infective regimens group...